She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) ...

Today, Benzinga's options scanner spotted 13 options trades for Amgen. This is not a typical pattern. The sentiment among ...

In much the same way people can "chat" with large language models like GPT-4, Stanford Health Care clinicians can now ...

After that nightmare staff meeting on Feb. 12, 2010 at which three of his colleagues were killed and three others wounded, Ng began asking his fellow survivors whether they developed health problems ...

Your kidneys are vital to your overall health. According to the US Centers for Disease Control and Prevention, more than one ...

Smartwatches have come a long way. What were originally clunky devices with limited functionality and poor battery life have quickly evolved into stylish s ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...

When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the ...

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

Merck & Co. said its oral PCSK9 inhibitor candidate enlicitide hit its key goals in a pair of late-stage studies in adults with high cholesterol. Merck, which is evaluating the safety and efficacy ...

Merck & Co., Inc. (NYSE:MRK) is one of the best Dow stocks to invest in. On June 9, the company announced that its drug, ...